Vol. 30 No. 3 (2013) | ALTEX - Alternatives to animal experimentation

Volume 30 - No. 3 - 2013

Contents

Food for Thought ...
Articles
Meeting Reports
Comments
Corrections
Corners
Calendar
Editorial Material

Editorial

Sonja von Aulock

pdf

Food for Thought ...

Look back in anger – what clinical studies tell us about preclinical work

Thomas Hartung

Vol. 30 No. 3 (2013), pp. 275-291
https://doi.org/10.14573/altex.2013.3.275

pdf

Articles

In vitro pituitary and thyroid cell proliferation assays and their relevance as alternatives to animal testing

Barae Jomaa, Jac M. M. J. G. Aarts, Laura H. J. de Haan [...] Ivonne M. C. M. Rietjens

Vol. 30 No. 3 (2013), pp. 293-307
https://doi.org/10.14573/altex.2013.3.293

pdf

In vitro to human in vivo translation – pharmacokinetics and pharmacodynamics of quinidine

Sebastian Polak

Vol. 30 No. 3 (2013), pp. 309-318
https://doi.org/10.14573/altex.2013.3.309

pdf sup

Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides

Karin Dreisig, Camilla Taxvig, Mia Birkhøj Kjærstad [...] Anne Marie Vinggaard

Vol. 30 No. 3 (2013), pp. 319-330
https://doi.org/10.14573/altex.2013.3.319

pdf sup

In vitro metabolism and bioavailability tests for endocrine active substances: What is needed next for regulatory purposes?

Miriam N. Jacobs, Susan C. Laws, Kate Willett, Pat Schmieder, Jenny Odum

Vol. 30 No. 3 (2013), pp. 331-351
https://doi.org/10.14573/altex.2013.3.331

pdf

In vitro testicular toxicity models: Opportunities for advancement via biomedical engineering techniques

Louise Parks Saldutti, Bruce K. Beyer, William Breslin [...] Jennifer C. Sasaki

Vol. 30 No. 3 (2013), pp. 353-377
https://doi.org/10.14573/altex.2013.3.353

pdf sup

Meeting Reports

Alternative methods: 3Rs, research and regulatory aspects

Francesca Caloni, Patrizia Costa, Gianni Dal Negro [...] Augusto Vitale

Vol. 30 No. 3 (2013), pp. 378-380
https://doi.org/10.14573/altex.2013.3.378

pdf

Comments

Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles

Daniel R. Dietrich, Sonja von Aulock, Hans Marquardt [...] Alan Harvey

Vol. 30 No. 3 (2013), pp. 381-385
https://doi.org/10.14573/altex.2013.3.381

pdf

Bayesian Network Integrated Testing Strategy and beyond

Federico M. Stefanini

Vol. 30 No. 3 (2013), pp. 386-390
https://doi.org/10.14573/altex.2013.3.386

pdf

Reply to: Bayesian Network Integrated Testing Strategy and beyond

Joanna Jaworska

Vol. 30 No. 3 (2013), pp. 391
https://doi.org/10.14573/altex.2013.3.391

pdf

Corrections

Erratum to Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

Nina Hasiwa, Mardas Daneshian, Peter Bruegger [...] Thomas Hartung

Vol. 30 No. 3 (2013), pp. 352
https://doi.org/10.14573/altex.2013.3.352

pdf

Corners

Vol. 30 No. 3 (2013), pp. 392-400

pdf

News

Vol. 30 No. 3 (2013), pp. 401-407

pdf

Calendar

Vol. 30 No. 3 (2013), pp. 308

pdf

Editorial Material

Imprint

Vol. 30 No. 3 (2013), pp. 408

pdf

Instructions to authors

Vol. 30 No. 3 (2013), pp. 292

pdf

Cover

Vol. 30 No. 3 (2013), pp.

pdf